| love potions vs Steve | 15–18 | 45.45% |
| love potions vs Reina | 9–22 | 29.03% |
| love potions vs Jin | 10–13 | 43.48% |
| love potions vs Lili | 9–13 | 40.91% |
| love potions vs King | 9–11 | 45.00% |
| love potions vs Eddy | 3–17 | 15.00% |
| love potions vs Yoshimitsu | 7–9 | 43.75% |
| love potions vs Hwoarang | 3–13 | 18.75% |
| love potions vs Kazuya | 11–5 | 68.75% |
| love potions vs Dragunov | 4–10 | 28.57% |
| love potions vs Paul | 4–9 | 30.77% |
| love potions vs Azucena | 5–8 | 38.46% |
| love potions vs Alisa | 3–9 | 25.00% |
| love potions vs Kuma | 5–6 | 45.45% |
| love potions vs Leroy | 3–8 | 27.27% |
| love potions vs Xiaoyu | 2–8 | 20.00% |
| love potions vs Jack-8 | 2–8 | 20.00% |
| love potions vs Jun | 2–8 | 20.00% |
| love potions vs Victor | 3–7 | 30.00% |
| love potions vs Leo | 6–3 | 66.67% |
| love potions vs Lee | 4–5 | 44.44% |
| love potions vs Asuka | 1–7 | 12.50% |
| love potions vs Claudio | 2–6 | 25.00% |
| love potions vs Law | 2–5 | 28.57% |
| love potions vs Bryan | 3–3–1 | 50.00% |
| love potions vs Raven | 4–3 | 57.14% |
| love potions vs Lars | 2–4 | 33.33% |
| love potions vs Nina | 3–3 | 50.00% |
| love potions vs Devil Jin | 2–3 | 40.00% |
| love potions vs Panda | 2–3 | 40.00% |
| love potions vs Shaheen | 2–2 | 50.00% |
| love potions vs Zafina | 2–2 | 50.00% |
| love potions vs Feng | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.